Company: DAWN
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064436
Chunk: 5

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Item 1
Chunk 5
---
Condensed Balance Sheets 

(in thousands, except share amounts) 

(unaudited)

     March 31,2025

     December 31,2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     33,358

     $
     124,968

     Short-term investments

     439,662

     406,752

     Accounts receivable, net

     18,054

     13,876

     Inventory

     3,565

     3,321

     Prepaid expenses and other current assets

     14,012

     13,413

     Total current assets

     508,651

     562,330

     Property and equipment, net

     2,508

     2,285

     Operating lease right-of-use asset

     2,577

     2,422

     Intangible assets, net

     20,405

     15,630

     Deposits and other long-term assets

     215

     121

     Total assets
      
     $
     534,356

     $
     582,788

     Liabilities and stockholders’ equity

     Current liabilities:

     Accounts payable
      
     $
     2,540

     $
     3,262

     Accrued expenses and other current liabilities

     43,641

     68,625

     Current portion of deferred revenue

     1,636

     1,554

     Current portion of operating lease liabilities

     62

     10

     Total current liabilities

     47,879

     73,451

     Long-term portion of deferred revenue

     3,350

     3,233

     Long-term portion of operating lease liabilities

     2,854

     2,592

     Other long-term liability

     761

     761

     Total liabilities

     54,844

     80,037

     Commitments and contingencies (Note 7)

     Stockholders’ equity:

     Common stock, $0.0001 par value; 500,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 101,353,781 and 101,116,162 shares issued and outstanding as of March 31,